{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T21:03:34Z","timestamp":1786914214668,"version":"build-2736575974"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,4]]},"DOI":"10.7759\/cureus.63858","type":"journal-article","created":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T21:06:03Z","timestamp":1720127163000},"source":"Crossref","is-referenced-by-count":1,"title":["A Case of Amiodarone-Induced Thyrotoxicosis Presenting With Methimazole-Induced Agranulocytosis"],"prefix":"10.7759","author":[{"given":"Neha","family":"Meda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suhail","family":"Saad-Omer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moises","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"Kinaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2023.03.204","article-title":"Between a rock and a hard place: a case of amiodarone induced thyrotoxicosis presenting with methimazole induced agranulocytosis","volume":"29","author":"Matos M","year":"2023","unstructured":"Matos M, Saad-Omer S, Kinaan. Between a rock and a hard place: a case of amiodarone induced thyrotoxicosis presenting with methimazole induced agranulocytosis. Endocr Pract. 2023, 29:91-2. 10.1016\/j.eprac.2023.03.204","journal-title":"Endocr Pract"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.160.12.1741","article-title":"Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology","volume":"160","author":"Goldschlager N","year":"2000","unstructured":"Goldschlager N, Epstein AE, Naccarelli G, Olshansky B, Singh B. Practical guidelines for clinicians who treat patients with amiodarone. Practice Guidelines Subcommittee, North American Society of Pacing and Electrophysiology. Arch Intern Med. 2000, 160:1741-8. 10.1001\/archinte.160.12.1741","journal-title":"Arch Intern Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(91)90187-3","article-title":"Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism","volume":"91","author":"Trip MD","year":"1991","unstructured":"Trip MD, Wiersinga W, Plomp TA. Incidence, predictability, and pathogenesis of amiodarone-induced thyrotoxicosis and hypothyroidism. Am J Med. 1991, 91:507-11. 10.1016\/0002-9343(91)90187-3","journal-title":"Am J Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1210\/endo-113-4-1464","article-title":"The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5'-monodeiodination in rats","volume":"113","author":"Sogol PB","year":"1983","unstructured":"Sogol PB, Hershman JM, Reed AW, Dillmann WH. The effects of amiodarone on serum thyroid hormones and hepatic thyroxine 5'-monodeiodination in rats. Endocrinology. 1983, 113:1464-9. 10.1210\/endo-113-4-1464","journal-title":"Endocrinology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-101-1-28","article-title":"Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy","volume":"101","author":"Martino E","year":"1984","unstructured":"Martino E, Safran M, Aghini-Lombardi F, et al.. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med. 1984, 101:28-34. 10.7326\/0003-4819-101-1-28","journal-title":"Ann Intern Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-0180","article-title":"Approach to the patient with amiodarone-induced thyrotoxicosis","volume":"95","author":"Bogazzi F","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E. Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2010, 95:2529-35. 10.1210\/jc.2010-0180","journal-title":"J Clin Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000486957","article-title":"2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction","volume":"7","author":"Bartalena L","year":"2018","unstructured":"Bartalena L, Bogazzi F, Chiovato L, Hubalewska-Dydejczyk A, Links TP, Vanderpump M. 2018 European Thyroid Association (ETA) guidelines for the management of amiodarone-associated thyroid dysfunction. Eur Thyroid J. 2018, 7:55-66. 10.1159\/000486957","journal-title":"Eur Thyroid J"},{"key":"ref8","article-title":"Amiodarone-induced thyroid dysfunction","volume":"95","author":"Ross IL","year":"2005","unstructured":"Ross IL, Marshall D, Okreglicki A, Isaacs S, Levitt NS. Amiodarone-induced thyroid dysfunction. S Afr Med J. 2005, 95:180-3.","journal-title":"S Afr Med J"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.78.2.8106631","article-title":"Serum interleukin-6 in amiodarone-induced thyrotoxicosis","volume":"78","author":"Bartalena L","year":"1994","unstructured":"Bartalena L, Grasso L, Brogioni S, Aghini-Lombardi F, Braverman LE, Martino E. Serum interleukin-6 in amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 1994, 78:423-7. 10.1210\/jcem.78.2.8106631","journal-title":"J Clin Endocrinol Metab"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1046\/j.0300-0664.2001.01457.x","article-title":"Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography","volume":"56","author":"Eaton SE","year":"2002","unstructured":"Eaton SE, Euinton HA, Newman CM, Weetman AP, Bennet WM. Clinical experience of amiodarone-induced thyrotoxicosis over a 3-year period: role of colour-flow Doppler sonography. Clin Endocrinol (Oxf). 2002, 56:33-8. 10.1046\/j.0300-0664.2001.01457.x","journal-title":"Clin Endocrinol (Oxf)"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1678","article-title":"Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study","volume":"96","author":"Bogazzi F","year":"2011","unstructured":"Bogazzi F, Bartalena L, Tomisti L, Rossi G, Brogioni S, Martino E. Continuation of amiodarone delays restoration of euthyroidism in patients with type 2 amiodarone-induced thyrotoxicosis treated with prednisone: a pilot study. J Clin Endocrinol Metab. 2011, 96:3374-80. 10.1210\/jc.2011-1678","journal-title":"J Clin Endocrinol Metab"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross DS","year":"2016","unstructured":"Ross DS, Burch HB, Cooper DS, et al.. 2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis. Thyroid. 2016, 26:1343-421. 10.1089\/thy.2016.0229","journal-title":"Thyroid"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.70.7.624","article-title":"Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies","volume":"70","author":"Cardenas GA","year":"2003","unstructured":"Cardenas GA, Cabral JM, Leslie CA. Amiodarone induced thyrotoxicosis: diagnostic and therapeutic strategies. Cleve Clin J Med. 2003, 70:624-6, 628-31. 10.3949\/ccjm.70.7.624","journal-title":"Cleve Clin J Med"},{"key":"ref14","article-title":"Perchlorate and the thyroid gland","volume":"50","author":"Wolff J","year":"1998","unstructured":"Wolff J. Perchlorate and the thyroid gland. Pharmacol Rev. 1998, 50:89-105.","journal-title":"Pharmacol Rev"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.86.1.7119","article-title":"Amiodarone-induced thyrotoxicosis","volume":"86","author":"Daniels GH","year":"2001","unstructured":"Daniels GH. Amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2001, 86:3-8. 10.1210\/jcem.86.1.7119","journal-title":"J Clin Endocrinol Metab"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1089\/thy.2018.0274","article-title":"Increased risk of antithyroid drug agranulocytosis associated with amiodarone-induced thyrotoxicosis: a population-based cohort study","volume":"29","author":"Gershinsky M","year":"2019","unstructured":"Gershinsky M, Saliba W, Lavi I, Shapira C, Gronich N. Increased risk of antithyroid drug agranulocytosis associated with amiodarone-induced thyrotoxicosis: a population-based cohort study. Thyroid. 2019, 29:193-201. 10.1089\/thy.2018.0274","journal-title":"Thyroid"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-004-7599-6","article-title":"Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience","volume":"28","author":"Houghton SG","year":"2004","unstructured":"Houghton SG, Farley DR, Brennan MD, van Heerden JA, Thompson GB, Grant CS. Surgical management of amiodarone-associated thyrotoxicosis: Mayo Clinic experience. World J Surg. 2004, 28:1083-7. 10.1007\/s00268-004-7599-6","journal-title":"World J Surg"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz041","article-title":"Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis","volume":"105","author":"Cappellani D","year":"2020","unstructured":"Cappellani D, Papini P, Pingitore A, et al.. Comparison between total thyroidectomy and medical therapy for amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab. 2020, 105:242-51. 10.1210\/clinem\/dgz041","journal-title":"J Clin Endocrinol Metab"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00259","article-title":"Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience","volume":"2","author":"Kotwal A","year":"2018","unstructured":"Kotwal A, Clark J, Lyden M, McKenzie T, Thompson G, Stan MN. Thyroidectomy for amiodarone-induced thyrotoxicosis: Mayo Clinic experience. J Endocr Soc. 2018, 2:1226-35. 10.1210\/js.2018-00259","journal-title":"J Endocr Soc"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/j.1444-0903.2004.00600.x","article-title":"Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis","volume":"34","author":"Diamond TH","year":"2004","unstructured":"Diamond TH, Rajagopal R, Ganda K, Manoharan A, Luk A. Plasmapheresis as a potential treatment option for amiodarone-induced thyrotoxicosis. Intern Med J. 2004, 34:369-70; author reply 370-1. 10.1111\/j.1444-0903.2004.00600.x","journal-title":"Intern Med J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/256407-a-case-of-amiodarone-induced-thyrotoxicosis-presenting-with-methimazole-induced-agranulocytosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T21:06:08Z","timestamp":1720127168000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/256407-a-case-of-amiodarone-induced-thyrotoxicosis-presenting-with-methimazole-induced-agranulocytosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,4]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.63858","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,4]]}}}